Ultrastructural myocardial changes in patients with severe aortic stenosis referred for surgical aortic valve replacement

Back

ESC Professional Premium Access

Ultrastructural myocardial changes in patients with severe aortic stenosis referred for surgical aortic valve replacement

Session: Cardiomyopathies in myocardial disease

Topic: Pathophysiology and Mechanisms

Speaker: Doctor R. Reis Santos (Lisbon, PT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Rita Reis Santos

Hospital Santa Cruz, Lisbon (Portugal)

1 follower

7 more presentations in this session

Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)

Speaker: Doctor N. Lakdawala (Boston, US)

Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

Speaker: Doctor H. Procter (Leeds, GB)

Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up

Speaker: Doctor M. Schiavo (Bologna, IT)

Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy

Speaker: Doctor E. Maksabedian Hernandez (Los Angeles, US)

Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement

Speaker: Doctor R. Baldassarre (Bologna, IT)

Access the full session

Cardiomyopathies in myocardial disease

Speakers: Doctor R. Reis Santos, Doctor N. Lakdawala, Doctor H. Procter, Doctor M. Schiavo, Doctor E. Maksabedian Hernandez...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Ultrastructural myocardial changes in patients with severe aortic stenosis referred for surgical aortic valve replacement

About the speaker

Doctor Rita Reis Santos

7 more presentations in this session

Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)

Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up

Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy

Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement

Access the full session

Cardiomyopathies in myocardial disease

About the event

ESC Congress 2023

ESC 365 is supported by